- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
BSG antibody, also known as Basigin antibody, recognizes CD147, a transmembrane glycoprotein encoded by the human BSG gene located on chromosome 19p13.3. Basigin is a member of the immunoglobulin superfamily and is widely referred to in the literature as CD147, Emmprin, and Extracellular matrix metalloproteinase inducer. BSG antibody detects a cell surface protein predominantly localized to the plasma membrane, where it regulates cell-cell interactions and extracellular signaling events.
Basigin contains two extracellular immunoglobulin-like domains, a single transmembrane segment, and a short cytoplasmic tail. Through its extracellular domains, CD147 interacts with integrins, cyclophilins, and matrix metalloproteinases, promoting extracellular matrix remodeling and intercellular communication. The Emmprin designation reflects its ability to stimulate matrix metalloproteinase production in adjacent stromal fibroblasts, contributing to tissue invasion and matrix degradation. BSG antibody supports research focused on these matrix-associated signaling mechanisms.
CD147 is broadly expressed in epithelial cells, endothelial cells, leukocytes, and numerous tumor cell types. Elevated expression has been documented in breast, lung, colorectal, hepatocellular, and head and neck cancers, where increased CD147 levels are associated with tumor progression, angiogenesis, and metastatic potential. In addition to its role in matrix remodeling, Basigin regulates cellular metabolism through its interaction with monocarboxylate transporters, facilitating lactate export in highly glycolytic tumor cells. BSG antibody is therefore frequently used in studies examining tumor metabolism and hypoxic microenvironments.
Beyond oncology, CD147 participates in immune and inflammatory signaling. It functions as a receptor for extracellular cyclophilins and contributes to leukocyte activation and chemotaxis. Expression is also observed in reproductive tissues and during development, reflecting broader roles in tissue remodeling and cellular differentiation. Clone BSG/7955 is developed to recognize CD147 for research applications. This antibody targets Basigin in research settings and supports investigations into cancer biology, inflammation, and metabolic regulation.
Optimal dilution of the BSG antibody should be determined by the researcher.
Recombinant full-length human protein was used as the immunogen for the CD147 antibody.
Aliquot the BSG antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.